Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
PR Lotion is a topical sports performance product containing sodium bicarbonate as its active ingredient, designed to be delivered transdermally to muscle tissue. Developed by AMP Human (which merged with or rebranded as Momentous), the lotion utilizes a proprietary delivery system to transport bicarbonate ions through the skin, bypassing the gastrointestinal tract to avoid the gastric distress often caused by oral bicarbonate loading. Its primary mechanism is to enhance the body's buffering capacity against metabolic acidosis by neutralizing hydrogen ions (lactic acid) produced during high-intensity exercise. This is intended to improve athletic performance, delay the onset of muscle fatigue, and support recovery by mitigating exercise-induced muscle damage and inflammation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on PR Lotion.